Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.72B | 2.72B | 2.60B | 2.32B | 2.01B | 1.90B |
Gross Profit | 419.90M | 408.80M | 376.90M | 295.70M | 276.80M | 265.70M |
EBITDA | 275.70M | 280.70M | 253.60M | 220.00M | 199.00M | 185.50M |
Net Income | 134.30M | 134.30M | 113.10M | 111.40M | 103.50M | 92.50M |
Balance Sheet | ||||||
Total Assets | 1.53B | 1.53B | 1.38B | 1.26B | 1.14B | 1.04B |
Cash, Cash Equivalents and Short-Term Investments | 5.90M | 5.90M | 27.00M | 20.40M | 200.00K | 39.90M |
Total Debt | 178.30M | 178.30M | 127.40M | 121.70M | 106.20M | 131.40M |
Total Liabilities | 543.30M | 543.30M | 472.50M | 421.50M | 373.60M | 355.00M |
Stockholders Equity | 987.90M | 987.90M | 911.50M | 842.90M | 768.90M | 686.10M |
Cash Flow | ||||||
Free Cash Flow | 78.70M | 78.70M | 127.90M | 64.10M | 64.70M | 109.00M |
Operating Cash Flow | 216.30M | 216.30M | 228.40M | 149.20M | 158.40M | 180.90M |
Investing Cash Flow | -160.40M | -160.40M | -123.30M | -83.80M | -130.90M | -81.80M |
Financing Cash Flow | -77.00M | -77.00M | -93.40M | -45.30M | -66.30M | -81.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | £2.73B | 20.27 | 14.14% | 1.98% | 4.77% | 18.94% | |
69 Neutral | 1.61B | 12.96 | 8.66% | 1.50% | 1.01% | 11.12% | |
67 Neutral | 2.24B | 35.50 | 8.99% | 3.91% | 5.40% | -67.46% | |
66 Neutral | 603.17M | 15.32 | 12.82% | 5.13% | 8.58% | -15.81% | |
64 Neutral | 1.05B | 19.74 | 10.28% | 0.83% | 0.49% | 14.18% | |
61 Neutral | 1.27B | 33.31 | 9.04% | 2.71% | 0.59% | -41.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Cranswick plc announced a transaction involving the reinvestment of dividends into shares by Sophia Bottomley, who is closely associated with John Mark Bottomley, a director at Cranswick. The transaction, involving 42 ordinary shares at a price of 5205.6p each, took place on the London Stock Exchange on September 12, 2025. This move reflects the company’s ongoing commitment to shareholder value and may indicate confidence in Cranswick’s market position and future prospects.
The most recent analyst rating on (GB:CWK) stock is a Buy with a £5802.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving Saskia Bottomley, who is closely associated with John Mark Bottomley, a Director at the company. The transaction involved the reinvestment of dividends into ordinary shares, with a total of 57 shares purchased at a price of 5205.6 pence each on the London Stock Exchange. This transaction reflects a strategic reinvestment approach by individuals closely linked to the company’s leadership, potentially indicating confidence in Cranswick’s market position and future prospects.
The most recent analyst rating on (GB:CWK) stock is a Buy with a £5802.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced that as of 10 September 2025, the company has a total of 54,270,567 ordinary shares in issue, each carrying one vote. This information is crucial for shareholders to determine their notification requirements regarding their interest in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £5530.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares under the company’s 2024 Buy As You Earn Share Incentive Plan. This transaction, part of a regular monthly purchase program, reflects ongoing confidence in the company’s strategic direction and its commitment to aligning management interests with those of shareholders.
The most recent analyst rating on (GB:CWK) stock is a Buy with a £62.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced that as of August 1, 2025, the total number of ordinary shares in its capital is 54,264,605, with each share granting one voting right. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that all resolutions proposed at its 2025 Annual General Meeting were successfully passed, with most receiving significant majorities. However, the resolution concerning the Directors’ Remuneration Report received less than 80% approval, prompting the Board to continue engaging with shareholders to address their concerns. This engagement reflects Cranswick’s commitment to aligning with shareholder expectations and adhering to the UK Corporate Governance Code.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick reported strong trading in the first quarter of the financial year, with a 9.7% increase in revenue compared to the previous year, driven by new business wins and strong demand for premium products. The acquisition of Blakemans contributed positively, and export revenue was bolstered by the reinstatement of the Norfolk pork site’s China export license. The company is accelerating capital expenditure to enhance capacity and efficiency, with significant investment in the Lincoln Pet Products site. Cranswick also refinanced its banking facility, securing a £360 million revolving credit facility to support future growth.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving the sale of 4,000 ordinary shares by Christie Brisby, the spouse of Director James Robert Brisby, on the London Stock Exchange. This transaction, disclosed as part of regulatory requirements, may impact the company’s stock dynamics and reflects internal managerial activities, potentially influencing stakeholder perceptions.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.